Historical salary details - Dr. Thomas F. Woiwode, PhD, Independent Director, Passage Bio Inc
Dr. Thomas F. Woiwode, PhD is the Independent Director of Passage Bio Inc. They also hold 1 other positions in and Tempest Therapeutics Inc.
Dr. Thomas F. Woiwode, Phd
Independent Director
$ 44.6 K
Gross Remuneration
-
Current Company
Passage Bio Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2023 | Passage Bio Inc | Independent Director | 44.6 K | -43.6 % |
| 2023 | Tempest Therapeutics Inc | Independent Director | - | - |
| 2022 | Passage Bio Inc | Independent Director | 79.1 K | -64.2 % |
| 2022 | Tempest Therapeutics Inc | Independent Director | 62.9 K | -15.1 % |
| 2022 | Aligos Therapeutics Inc | Independent Director | 57.6 K | -80.4 % |
| 2021 | Aligos Therapeutics Inc | Independent Director | 293.8 K | 3091.0 % |
| 2021 | Passage Bio Inc | Independent Director | 221.0 K | -56.1 % |
| 2021 | Adverum Biotechnologies Inc | - | 152.4 K | -74.3 % |
| 2021 | Tempest Therapeutics Inc | Independent Director | 74.1 K | - |
| 2021 | Gritstone Bio Inc | - | 22.5 K | -78.2 % |
| 2021 | Adverum Biotechnologies Inc | Independent Director | - | - |
| 2021 | Gritstone Bio Inc | Independent Director | - | - |
| 2020 | Adverum Biotechnologies Inc | Independent Director | 592.4 K | 26.5 % |
| 2020 | Passage Bio Inc | Independent Director | 503.8 K | - |
| 2020 | Gritstone Bio Inc | Independent Director | 103.1 K | -7.0 % |
| 2020 | Aligos Therapeutics Inc | Independent Director | 9.2 K | - |
| 2020 | Tempest Therapeutics Inc | Director | - | - |
| 2019 | Adverum Biotechnologies Inc | Independent Director | 468.1 K | - |
| 2019 | Gritstone Bio Inc | Independent Director | 110.9 K | 805.7 % |
| 2019 | CRISPR Therapeutics AG | - | 20.2 K | -96.9 % |
| 2019 | Aligos Therapeutics Inc | Independent Director | - | - |
| 2019 | CRISPR Therapeutics AG | Independent Director | - | - |
| 2019 | Passage Bio Inc | Independent Director | - | - |
| 2018 | CRISPR Therapeutics AG | Independent Director | 641.8 K | 261.6 % |
| 2018 | Gritstone Bio Inc | Independent Director | 12.3 K | - |
| 2018 | Adverum Biotechnologies Inc | Independent Director | - | - |
| 2017 | Adverum Biotechnologies Inc | Independent Director | 222.5 K | -24.3 % |
| 2017 | CRISPR Therapeutics AG | Independent Director | 177.5 K | -41.8 % |
| 2017 | Gritstone Bio Inc | Independent Director | - | - |
| 2016 | CRISPR Therapeutics AG | Independent Director | 304.8 K | 201.1 % |
| 2016 | Adverum Biotechnologies Inc | Independent Director | 293.8 K | - |
| 2015 | CRISPR Therapeutics AG | Independent Director | 101.2 K | - |